Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Short term Debt (2016 - 2025)

Historic Short term Debt for Palisade Bio (PALI) over the last 11 years, with Q3 2025 value amounting to $235000.0.

  • Palisade Bio's Short term Debt changed N/A to $235000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $235000.0, marking a year-over-year change of. This contributed to the annual value of $143000.0 for FY2023, which is N/A changed from last year.
  • Palisade Bio's Short term Debt amounted to $235000.0 in Q3 2025.
  • Over the past 5 years, Palisade Bio's Short term Debt peaked at $1.1 million during Q2 2021, and registered a low of $66000.0 during Q2 2025.
  • Moreover, its 4-year median value for Short term Debt was $143000.0 (2023), whereas its average is $278000.0.
  • Data for Palisade Bio's Short term Debt shows a peak YoY increase of 5174.83% (in 2025) and a maximum YoY decrease of 5570.47% (in 2025) over the last 5 years.
  • Palisade Bio's Short term Debt (Quarter) stood at $1.1 million in 2021, then tumbled by 87.47% to $143000.0 in 2023, then grew by 4.2% to $149000.0 in 2024, then skyrocketed by 57.72% to $235000.0 in 2025.
  • Its Short term Debt was $235000.0 in Q3 2025, compared to $66000.0 in Q2 2025 and $69000.0 in Q1 2025.